Mucurmicosis rinocerebral en un paciente con diabetes descompensada
نویسندگان
چکیده
La mucormicosis es una infección con alta mortalidad, el pronóstico está en relación diagnóstico precoz, tratamiento quirúrgico y antimicótico. Se presenta un varón de 65 años edad, hipertenso conocido, tratado losartan, ingresa historia 15 días evolución astenia, anorexia, pérdida peso cefalea holocraneana, ptosis palpebral semana evolución. Al examen físico se constata protrusión ocular parálisis del tercer par ojo derecho. Presentó hiperglicemia que fue revertida insulina. resonancia magnética órbita senos paranasales mostró engrosamiento nervio óptico derecho, ocupación los paranasales. El paciente sometido a la lesión retrocular, biopsia al directo hifas hialinas compatible mucorales. inició amfotericina B.
منابع مشابه
Paniculitis en paciente con dermatomiositis
Panniculitis is a rarely reported clinical finding in dermatomyositis. It may precede the other manifestations associated with dermatomyositis by as much as 14 months. In all cases, myositis and panniculitis improve simultaneously during treatment. The present report describes the case of a 30-year-old female patient with clinical and histopathological findings consistent with panniculitis two ...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista científica ciencias de la salud
سال: 2023
ISSN: ['2664-2891']
DOI: https://doi.org/10.53732/rccsalud/2023.e5201